H Ahn
Overview
Explore the profile of H Ahn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng W, Jarawan E, Bajnauth D, Ding Y, Marquez P, Wang H, et al.
Public Health
. 2022 Jun;
207:127-128.
PMID: 35660732
No abstract available.
2.
Canizares M, Glennie R, Perruccio A, Abraham E, Ahn H, Attabib N, et al.
Spine J
. 2020 Feb;
20(4):674.
PMID: 32081566
No abstract available.
3.
Cho H, Ahn H, Lee J, Jung Y, Chang Y, Nam J, et al.
J Viral Hepat
. 2018 Jan;
25(6):707-717.
PMID: 29316069
Nucleos(t)ide analogues (NAs) have been shown to decrease the risk of hepatocellular carcinoma (HCC) recurrence. This study evaluated whether high-potency NAs (entecavir and tenofovir disoproxil fumarate [TDF]) reduce the risk...
4.
Choi S, Oh H, Choi C, Ahn H, Yun H, Chung Y, et al.
J Appl Microbiol
. 2017 Nov;
124(3):821-828.
PMID: 29130606
Aims: In this study, we evaluated the therapeutic efficacy of selected probiotics in a mouse model of birch pollen (BP)-induced allergic rhinitis. Methods And Results: Oral administration of Lactobacillus plantarum...
5.
Glennie R, Bailey C, Tsai E, Noonan V, Rivers C, Fourney D, et al.
Spinal Cord
. 2017 Apr;
55(6):618-623.
PMID: 28418395
Study Design: Retrospective analysis of a prospective registry and surgeon survey. Objectives: To identify surgeon opinion on ideal practice regarding the timing of decompression/stabilization for spinal cord injury and actual...
6.
Kim A, Yu B, Dueker S, Shin K, Kim H, Ahn H, et al.
Clin Pharmacol Ther
. 2017 Feb;
102(3):537-546.
PMID: 28214288
C-labeled YH4808, a novel potassium-competitive acid blocker, was intravenously administered as a microtracer at 80 μg (11.8 kBq or 320 nCi) concomitantly with the nonradiolabeled oral drug at 200 mg...
7.
Kim H, Seo J, Kim K, Ahn H, Jeong J, Kim J, et al.
Andrologia
. 2015 Nov;
48(6):654-61.
PMID: 26589369
Recent meta-analysis by the Cochrane collaboration concluded that treatment of varicocele may improve an infertile couple's chance of pregnancy. However, there has been no consensus on the management of subclinical...
8.
Lee J, Kim M, Park I, Ahn J, Lee D, Ryoo H, et al.
Ann Oncol
. 2015 Sep;
26(11):2300-5.
PMID: 26347107
Background: The standard sunitinib schedule, 4 weeks on, followed by 2 weeks off (4/2 schedule), is associated with troublesome toxicities, and maintenance of adequate sunitinib dosing and drug levels, which...
9.
Jager D, Ma J, Mardiak J, Ye D, Korbenfeld E, Zemanova M, et al.
Clin Genitourin Cancer
. 2014 Dec;
13(2):156-64.e1.
PMID: 25444666
Background: Patients with advanced renal cell carcinoma in routine clinical practice can differ considerably from those in phase III studies. Patients And Methods: PREDICT (Patient characteristics in REnal cell carcinoma...
10.
Choi Y, Lee S, Lee J, Ahn J, Lee K, You D, et al.
Br J Cancer
. 2014 Nov;
112(2):260-5.
PMID: 25429526
Background: Pemetrexed has shown a favourable response rate of about 30% with minimal toxicity when used as a single agent for treatment of advanced urothelial carcinoma. This phase II study...